• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 502155 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1419051551 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1419051551 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Sangamo Biosciences Earnings In Retrospect: Up 7.1% in the Last 10 Days (SGMO)

Published on Sat, 05/18/2013 - 09:15
By Robert Cotter

When Sangamo Biosciences (NASDAQ:SGMO) reported earnings a week ago on May 8th, 2013, analysts, on average, expected the company to report a loss of $0.14 on sales of $4.0 million. Sangamo Biosciences actually reported a loss of $0.13 per share on sales of $4.6 million, beating EPS estimates by $0.01 and beating revenue estimates by $0.6 million. Since the company's report, shares of Sangamo Biosciences have risen from $7.87 to $8.43, representing a gain of 7.1% in the past 10 days.

Sangamo BioSciences, Inc. researches and develops transcription factors in the regulation of genes. These transcription factors are the proteins that turn genes on and off and regulate gene expression by recognizing specific DNA sequences.

Sangamo Biosciences (NASDAQ:SGMO) has potential upside of 106.4% based on a current price of $8.43 and analysts' consensus price target of $17.40. The stock should find resistance at its 50-day moving average (MA) of $9.40, as well as support at its 200-day MA of $7.31.

Over the past year, Sangamo Biosciences has traded in a range of $4.04 to $11.24 and closed Thursday at $8.43, 109% above that low. Over the past week, the 200-day moving average (MA) has gone up 1.1% while the 50-day MA has declined 1.7%.

By Robert Cotter
rcotter@fnno.com

Latest News from FNNO

Shares of Wells Fargo Rise to a New 52-W...

Wells Fargo (NYSE:WFC) traded at a new 52-week high today of $55.42. Approximately 20. ...

Watch for Continued Gains in Shares of W...

Wisconsin Energy (NYSE:WEC) traded today at a new 52-week high of $52.50. So far today ...

Recent 52-Week High Exceeded in Shares o...

Shares of Western Digital (NYSE:WDC) traded today at $114.69, breaking its 52-week high ...

WellCare Health Plans: The Winning Strea...

Shares of WellCare Health Plans (NYSE:WCG) traded at a new 52-week high today of $80.95 ...

Vertex Pharmaceuticals Looks to Continue...

Vertex Pharmaceuticals (NASDAQ:VRTX) traded at a new 52-week high today of $123.82. Th ...

Shares of Vornado Realty Trust Rise Abov...

Shares of Vornado Realty Trust (NYSE:VNO) traded today at $117.37, breaking its 52-week ...

US Bancorp Looks to Continue to Trade Ab...

Shares of US Bancorp (NYSE:USB) traded today at $45.54, breaking its 52-week high. So ...

United Parcel Service Looks to Continue ...

United Parcel Service (NYSE:UPS) traded today at a new 52-week high of $111.99. So far ...